Stephen Fawell

Insider Reports History

Location
Watertown, MA
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Fawell:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Director Stock Option (Right to Buy) 35,500 18 Jun 2025 Direct

Insider Reports Filed by Stephen Fawell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 18 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:11
CCCC C4 Therapeutics, Inc. 29 Aug 2024 1 $0 4 Director 03 Sep 2024, 16:52
CCCC C4 Therapeutics, Inc. 29 Aug 2024 0 $0 3 Director 03 Sep 2024, 16:51